These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4982 related articles for article (PubMed ID: 3327627)

  • 1. Histological localization of 4-S-cysteinylphenol in melanoma-bearing mice.
    Nakamura T; Matsubara O; Kasuga T; Suzuki J; Ishikawa K; Ito S
    Bull Tokyo Med Dent Univ; 1987 Dec; 34(4):93-8. PubMed ID: 3327627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
    Yamada K; Jimbow K
    Melanoma Res; 1992 Nov; 2(4):225-33. PubMed ID: 1490110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
    Alena F; Iwashina T; Gili A; Jimbow K
    Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific incorporation of 4-S-cysteinylphenol into human melanoma cells.
    Nakamura T; Seki S; Matsubara O; Ito S; Kasuga T
    J Invest Dermatol; 1988 May; 90(5):725-8. PubMed ID: 3361142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 1,2:5,6-dianhydrogalactitol and 1,2:5,6-dianhydro-3,4-diacetylgalactitol on DNA synthesis in the cells of melanoma B16, bone marrow, small intestine epithelium, spleen and liver of mice].
    Sokolova IS; Elekes I; Otvös L; Gorbacheva LB
    Biull Eksp Biol Med; 1984 Sep; 98(9):301-3. PubMed ID: 6487788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo].
    Shkarin PIu; Sokolova IS; Gorbacheva LB; Sibel'dina LA
    Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
    Miura T; Jimbow K; Ito S
    Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.
    Jimbow K; Miura T; Ito S; Ishikawa K
    Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.
    Miura S; Ueda T; Jimbow K; Ito S; Fujita K
    Arch Dermatol Res; 1987; 279(4):219-25. PubMed ID: 3674957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
    Reszka R; Beck P; Fichtner I; Hentschel M; Richter J; Kreuter J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):232-7. PubMed ID: 8996201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
    Staib L; Harel W; Mitchell MS
    Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a new benzodiazepine derivative on experimental malignant melanomas].
    Werner W; Wohlrabe K; Fichtner I; Wohlrab W
    Arch Geschwulstforsch; 1987; 57(1):17-23. PubMed ID: 3566461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.
    Ogawa Y; Kawamura T; Furuhashi M; Tsukamoto K; Shimada S
    J Dermatol Sci; 2008 Sep; 51(3):190-9. PubMed ID: 18485676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells.
    Kouzi-Koliakos K; Koliakos G; Trontzos C; Papageorgiou A; Iliadis S; Triantos A; Dimitriadou A; Kanellaki M
    Invasion Metastasis; 1996; 16(6):322-9. PubMed ID: 9371232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
    Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and metabolism of orally administered mitozolomide in mice.
    Gachon F; Labarre P; Godeneche D; Moreau MF; Papon J; Madelmont JC; Veyre A; Gaillard G
    Drug Metab Dispos; 1993; 21(4):560-6. PubMed ID: 8104113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damages of DNA synthesis in normal and tumor cells with sugar alcohol derivatives.
    Sokolova IS; Elekes I; Otvös L; Gorbacheva LB
    Neoplasma; 1984; 31(6):667-73. PubMed ID: 6521797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
    Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
    Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-selective action of 4-hydroxyanisole on melanoma cells in vivo.
    Schwabe K; Fichtner I; Tschiersch B
    Pigment Cell Res; 1990; 3(1):8-10. PubMed ID: 2116000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 250.